Palifermin (a RHUKGF molecule) is safe and well tolerated in patients with hematologic malignancies (HM) undergoing high-dose chemoradiotherapy (HD-CRT) followed by allogeneic hematopoietic stem cell transplantation (HSCT)

✍ Scribed by B.R. Blazar; D.J. Weisdorf; T.E. DeFor; A.I. Goldman; S. Silver; J.L.M. Ferrara

• Book ID: 116277969
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 55 KB
• Volume: 11
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2004.12.012